JPH0699318B2 - Antidiabetic agent consisting of water-soluble extract from Toberaceae plant - Google Patents

Antidiabetic agent consisting of water-soluble extract from Toberaceae plant

Info

Publication number
JPH0699318B2
JPH0699318B2 JP4320565A JP32056592A JPH0699318B2 JP H0699318 B2 JPH0699318 B2 JP H0699318B2 JP 4320565 A JP4320565 A JP 4320565A JP 32056592 A JP32056592 A JP 32056592A JP H0699318 B2 JPH0699318 B2 JP H0699318B2
Authority
JP
Japan
Prior art keywords
water
solution
toberaceae
extract
plant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP4320565A
Other languages
Japanese (ja)
Other versions
JPH05271086A (en
Inventor
明臣 山口
Original Assignee
明臣 山口
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 明臣 山口 filed Critical 明臣 山口
Priority to JP4320565A priority Critical patent/JPH0699318B2/en
Publication of JPH05271086A publication Critical patent/JPH05271086A/en
Publication of JPH0699318B2 publication Critical patent/JPH0699318B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、トベラ科植物からの糖
尿病の治療に有効な水溶性抽出物に関する。
FIELD OF THE INVENTION The present invention relates to a water-soluble extract which is effective for the treatment of diabetes from plants of the family Tiberaceae.

【0002】[0002]

【従来の技術】ビタミン B12は別名、コバラミンと称さ
れ動物蛋白因子であり、かつては動物より極微量しか抽
出できず、現在では微生物から抽出されている。また、
コバラミンは需要が増大している。
2. Description of the Related Art Vitamin B12, which is also known as cobalamin, is an animal protein factor, which was once extracted from animals in extremely small amounts, and is now extracted from microorganisms. Also,
Demand for cobalamin is increasing.

【0003】[0003]

【発明の構成】本発明者は、トベラ科植物からの抽出物
にビタミン B12が存在していることを見出し、そしてこ
の抽出物がこの植物性ビタミン B12あるいは他の未確認
成分の存在に起因するのかどうか未だ分かっていない
が、糖尿病の治療に非常に有効であることを見出した。
The present inventor has found that vitamin B12 is present in extracts from plants of the family Tiberaceae, and whether this extract is due to the presence of this vegetable vitamin B12 or other unidentified components. I don't know yet, but I found it very effective in treating diabetes.

【0004】従って、本発明は、トベラ科植物からの抽
出物より成る糖尿病治療剤に関する。この抽出物は、凍
結乾燥した粉末について分析したところによると、10 g
当たり2.0 μg のビタミンB12 、9.5mg のビタミンB2、
2.5gのタンニンおよびその他の未分析成分を含有し、量
は未測定であるが希少量のサポニンも含まれている。
Therefore, the present invention relates to a therapeutic agent for diabetes which comprises an extract from a plant of the family Tiberaceae. This extract contained 10 g of lyophilized powder when analyzed.
2.0 μg Vitamin B12, 9.5 mg Vitamin B2 per
It contains 2.5 g of tannin and other unanalyzed constituents, although the quantity is undetermined but also contains a small amount of saponin.

【0005】本発明の抽出物は、トベラ科植物、例えば
コンゴウコウハ(Pittosporum glabratum Lindl) 、崖花
子(Pittosporum glabratum Lindl) 、トベラ(Pittospor
um Tobira Ait)、シマトベラ(Pitto- sporum undulatum
Vent)等から以下の方法によって抽出される:トベラ科
植物の根、茎、葉等を乾燥した粉末にし、水──好まし
くは、粉末の数倍の量──と混合し、数日間に渡って放
置すると、水溶液と沈澱物との二層に分離する。水溶液
を減圧下に体温に近い40℃程度の温度において沸騰状態
で水分を蒸発させて濃縮する。こうして濃縮されたもの
が抽出物を含有した溶液である。この溶液を -30〜-40
℃の温度に急速凍結してそして次に 1〜0.01mmHgの減圧
状態で水の昇華により徐々に常温に到るまで乾燥する凍
結乾燥法によって粉末化することができる。
The extract of the present invention is a plant of the family Toberaceae, such as, for example, Pttosporum glabratum Lindl, Pittosporum glabratum Lindl, and Tobera Pittospor.
um Tobira Ait), Shimatobera (Pitto- sporum undulatum)
Vent) etc. by the following method: The roots, stems, leaves, etc. of Toberaceae plants are made into a dry powder and mixed with water--preferably several times as much as the powder--and allowed to stand for several days. When left to stand, it separates into two layers, an aqueous solution and a precipitate. The aqueous solution is concentrated under reduced pressure by evaporating water in a boiling state at a temperature of about 40 ° C close to body temperature. The solution thus concentrated is the solution containing the extract. Add this solution from -30 to -40
It can be freeze-dried to a temperature of ℃ and then powdered by a freeze-drying method in which it is dried by sublimation of water under a reduced pressure of 1 to 0.01 mmHg until it reaches a room temperature.

【0006】この粉末状抽出物を等量の水に溶解して測
定して赤外線吸収スペクトル分析すると、第 1図に記載
した如き赤外線吸収スペクトルを示す。即ち、このスペ
クトルは、以下の特徴的な吸収バンドを示している: 大きい吸収バンド: 1050〜1070cm-1、1620cm-1、2950cm
-1および3450cm-1 比較的大きい吸収バンド: 520 cm-1、780 cm-1、1250cm
-1、1320cm-1、1380〜1440cm-1のダブレット(台形)、17
35cm-1および2850cm-1 従って、本発明で用いる抽出物は、トベラ科植物の乾燥
粉末を水と混合して放置することによって、溶液層およ
び沈澱層二層に分離し、沈澱層を除いた後の溶液層を最
高40℃程度の低い温度で減圧下に濃縮して濃厚溶液とし
そして必要に応じて凍結乾燥により粉末化することによ
って得られ、且つ下記赤外線吸収スペクトルを示し: 大きい吸収バンド: 1050〜1070cm-1、1620cm-1、2950cm
-1および3450cm-1 比較的大きい吸収バンド: 520 cm-1、780 cm-1、1250cm
-1、1320cm-1、1380〜1440cm-1のダブレット(台形)、17
35cm-1および2850cm-1 そして主要成分としてビタミン B12、ビタミンB2、サボ
ニン、タンニンを含有する水溶性抽出物より成る、糖尿
病治療剤にある。
The powdery extract was dissolved in an equal amount of water, measured, and analyzed by infrared absorption spectrum. As a result, an infrared absorption spectrum as shown in FIG. 1 was obtained. That is, the spectrum shows characteristic absorption bands of the following: a large absorption band: 1050~1070cm -1, 1620cm -1, 2950cm
-1 and 3450 cm -1 Relatively large absorption bands: 520 cm -1 , 780 cm -1 , 1250 cm
-1 , 1320cm -1 , 1380-1440cm -1 doublet (trapezoid), 17
35 cm -1 and 2850 cm -1 Thus, extracts used in the present invention, by a dry powder of pittosporaceae plants to stand by mixing with water, separating the solution layer and precipitate layer two layers, except the precipitate layer The latter solution layer was obtained by concentrating under reduced pressure at a temperature as low as about 40 ° C. to form a concentrated solution and, if necessary, pulverizing by freeze-drying, and showed the following infrared absorption spectrum: large absorption band: 1050~1070cm -1, 1620cm -1, 2950cm
-1 and 3450 cm -1 Relatively large absorption bands: 520 cm -1 , 780 cm -1 , 1250 cm
-1 , 1320cm -1 , 1380-1440cm -1 doublet (trapezoid), 17
35 cm -1 and 2850 cm -1 and vitamin B12 as a main component, vitamin B2, saponin, consisting a water-soluble extract containing tannins, in diabetes treatment agent.

【0007】かゝる治療薬として上記抽出物を使用する
場合には、減圧濃縮後の凍結乾燥前の溶液としてそのま
ゝでまたはそれを希釈して使用することができるが、更
に凍結乾燥することによって粉末化して使用するのが特
に有利である。凍結乾燥物も水に容易に溶解することか
ら、水に溶解して使用することができるが、しかし凍結
乾燥粉末を乳糖等の賦形剤の混入によって散剤または錠
剤として経口投与することもできる。
When the above extract is used as such a therapeutic agent, it can be used as it is or as a solution before freeze-drying after concentration under reduced pressure, or it can be further freeze-dried. It is particularly advantageous to use it in the form of powder. Since the lyophilized product is also easily dissolved in water, it can be used by dissolving it in water, but the lyophilized powder can also be orally administered as a powder or tablet by mixing an excipient such as lactose.

【0008】投与量は、例えば溶液状態で経口投与する
場合には、一般に50〜600mg/l の濃度の抽出液を約100m
I / 回ずつ 2〜4 回で有効である。しかし上述の如く凍
結乾燥した粉末を10〜20倍散として経口投与するのが好
ましい。
For oral administration in the form of a solution, for example, an extract having a concentration of 50 to 600 mg / l is generally used in an amount of about 100 m.
Effective at 2 to 4 times per I / times. However, it is preferred that the freeze-dried powder as described above be orally administered as a 10 to 20-fold powder.

【0009】上記抽出物の急性毒性は、毒性が極少な
く、ラットによる経口投与にて粉末を10倍に希釈したも
ので測定したところ物理的に許容できる範囲内では無害
であつた。
The acute toxicity of the above extract was extremely low, and it was found to be harmless within a physically acceptable range when measured with a 10-fold diluted powder by oral administration in rats.

【0010】[0010]

【実施例】以下に本発明を実施例によって更に詳細に説
明する。実施例1 コンゴウコウハ(Pittosporum glabratum Lindl) と崖花
子(Pittosporum glabratum Lindl) とを互いに等量づ
つ、それぞれ葉を 6ケ月間、根及び茎を 1年間陰干して
から粉末にする。第 2図に記載した装置において、200g
のこの粉末を網で構成されている内部容器(2) に入れ
る。この(2) の容器の外側に配置された容器(1) に、1
リットルの水を導入して、粉末を水中に完全に浸漬させ
る。この状態で加温しながら約40℃に保持する。加温時
間は 5日間である。この時間の経過後に、外側容器には
水溶液層(a) と(2) の容器から出た微細粉末沈澱層(b)
が認められる。(2) の容器中には粗大のまゝの沈澱物層
(c) が残留する。(b) 及び(c)の層を除き、得られる850
mlの水溶液層(a) だけを容器中に残留させる。この水
溶液の濃度は15g/l である。この水溶液を、真空ポンプ
(3) により減圧状態として約40℃の温度のもとで濃縮し
て、353 mlの濃厚溶液を得る。濃縮された抽出物溶液の
濃度は、36.5g/l である。 この溶液を、-30 ℃で急速
凍結し、次いで 3時間の間に室温に到るまで 0.1〜0.3
mmHgの減圧状態を維持する。この凍結乾燥によって 1.1
0gの褐色の粉末が得られる。この粉末は水に無制限に溶
解することができる。
EXAMPLES The present invention will be described in more detail below with reference to examples. Example 1 Equally equal amounts of Plutosporum glabratum Lindl and Pittosporum glabratum Lindl are placed on the leaves for 6 months, and the roots and stems are shade-dried for 1 year before powdering. In the device shown in Fig. 2, 200 g
The powder of this is put into the inner container (2) composed of a net. In the container (1) placed outside this (2) container,
Introduce 1 liter of water to completely submerge the powder in water. In this state, keep the temperature at about 40 ℃ while heating. The heating time is 5 days. After this time, the outer container contained the aqueous layer (a) and the fine powder precipitate layer (b) from the container (2).
Is recognized. Coarse coarse sediment layer in the container of (2)
(c) remains. 850 obtained, except for layers (b) and (c)
Only ml of the aqueous layer (a) remains in the container. The concentration of this aqueous solution is 15 g / l. Vacuum pump this aqueous solution
Decompress under (3) and concentrate at a temperature of about 40 ° C to obtain a concentrated solution of 353 ml. The concentration of the concentrated extract solution is 36.5 g / l. The solution was snap frozen at -30 ° C and then allowed to reach room temperature within 3 hours at 0.1-0.3.
Maintain a reduced pressure of mmHg. 1.1 by this lyophilization
0 g of brown powder is obtained. This powder is freely soluble in water.

【0011】実施例 2( 試験) この粉末に二倍量の水を添加して溶解し、これについて
赤外線吸収スペクトル測定を行った。結果を第 1図に示
す。
Example 2 (Test) To this powder was added twice the amount of water to dissolve it, and the infrared absorption spectrum of this was measured. The results are shown in Fig. 1.

【0012】また上記粉末状抽出物に含まれる成分を種
々の方法によって測定した。結果と測定法を以下に示
す: ビタミンB12 2.0μg/10g 微生物定量法*) ビタミンB 2 9.5mg /10g ルミフラビン 蛍光光度法 タンニン 2.5g /10g FOLIN-DENIS 法 *) 使用菌株: Lactobacillus leichmannii AT CC 7830 その他の成分は、未測定のままである。
The components contained in the above powdery extract were measured by various methods. The results and measurement methods are shown below: Vitamin B12 2.0 μg / 10g Microbiological method *) Vitamin B2 9.5mg / 10g Lumiflavin Fluorescence method Tannin 2.5g / 10g FOLIN-DENIS method *) Strains used: Lactobacillus leichmannii AT CC 7830 The other components remain unmeasured.

【0013】実施例 3( 使用例) 本発明の抽出物を、凍結乾燥後の粉末を10倍量の水で希
釈した溶液状態で糖尿病患者及び肝臓疾患の患者に対し
て適用した結果を以下に説明する。
Example 3 (Use Example) The results of applying the extract of the present invention to diabetic patients and patients with liver diseases in the form of a solution prepared by diluting powder after freeze-drying with 10 times the amount of water are shown below. explain.

【0014】糖尿病の患者の治療に、上記の抽出物希釈
溶液を一日 1.5g 分3回投与した。第一の患者は、40才
の女性で投与前には 166mg/dl の血糖値であったのに75
日後には142mg/dlに、90日後には120 mg/dl にそして13
0 日後には 110mg/dl の正常値( 正常値60〜110 mg/dl)
にまで低下した。
For the treatment of diabetic patients, the above diluted solution of the extract was administered at a dose of 1.5 g three times a day. The first patient was a 40-year-old woman with a blood glucose level of 166 mg / dl before administration, but 75
142 mg / dl after 90 days, 120 mg / dl after 90 days and 13
Normal value of 110 mg / dl after 0 days (normal value 60-110 mg / dl)
Fell to.

【0015】第二の患者は、52才の女性で投与前には20
4mg/dlの血糖値であったのに60日後には166 mg/dl に、
75日後には140mg/dlにそして90日後には106mg/dlの正常
値にまで低下した。
The second patient is a 52 year old female, 20 before administration.
The blood glucose level was 4 mg / dl, but after 60 days it was 166 mg / dl,
It dropped to a normal value of 140 mg / dl after 75 days and 106 mg / dl after 90 days.

【0016】以上に示した効果から判るように、本発明
の抽出物は糖尿病の治療に非常に有効であることが判っ
ている。
As can be seen from the above-mentioned effects, the extract of the present invention has been found to be very effective in treating diabetes.

【0017】[0017]

【発明の効果】上記に説明した通り、トベラ科植物から
の抽出物は、植物に存在していないと信じられていたビ
タミンB12 を含有しておりそして驚くべきことに糖尿病
治療に非常に優れた薬効を示す。
INDUSTRIAL APPLICABILITY As explained above, the extract from the plants of the family Toberaceae contains vitamin B12, which was believed to be absent in the plant, and, surprisingly, is very excellent for the treatment of diabetes. Show medicinal effects.

【図面の簡単な説明】[Brief description of drawings]

【図1】図1は、本発明の一つの実施形態である実施例
1で得られた粉末抽出物の赤外線吸収スペクトルであ
る。
FIG. 1 is an example of an embodiment of the present invention.
2 is an infrared absorption spectrum of the powder extract obtained in 1.

【図2】図2は、実施例 1に記載の抽出法にて使用した
抽出装置を示している。図2中の記号は以下の意味を有
する: 1・・・外側容器 2・・・網製内部容器 3・・・真空ポンプ a・・・水溶性層 b・・・微細粉末沈澱層 c・・・粗大沈澱物の層
FIG. 2 shows an extraction apparatus used in the extraction method described in Example 1. The symbols in FIG. 2 have the following meanings: 1 ... Outer container 2 ... Net inner container 3 ... Vacuum pump a ... Water-soluble layer b ... Fine powder precipitation layer c ... .Large sediment layer

Claims (1)

【特許請求の範囲】[Claims] 【請求項1】 トベラ科植物の乾燥粉末を水と混合して
放置することによって、溶液層および沈澱層の二層に分
離し、沈澱層を除いた後に溶液層を最高40℃程度の低い
温度で減圧下に濃縮して濃厚溶液としそして必要に応じ
て凍結乾燥により粉末化することによって得られ、且つ
下記赤外線吸収スペクトルを示し: 大きい吸収バンド: 1050〜1070cm-1、1620cm-1、2950cm
-1および3450cm-1 比較的大きい吸収バンド: 520 cm-1、780 cm-1、1250cm
-1、1320cm-1、1380〜1440cm-1のダブレット(台形)、17
35cm-1および2850cm-1 そして主要成分としてビタミン B12、ビタミンB2、サボ
ニン、タンニンを含有する水溶性抽出物より成る糖尿病
及治療剤。
1. A dry powder of a Toberaceae plant is mixed with water and left to separate into two layers, a solution layer and a precipitation layer. After the precipitation layer is removed, the solution layer is heated at a low temperature of about 40 ° C. at the maximum. in obtained by powdered by lyophilization, if concentrated to a thick solution and necessary under reduced pressure, and yielded the following infrared absorption spectrum: a large absorption bands: 1050~1070cm -1, 1620cm -1, 2950cm
-1 and 3450 cm -1 Relatively large absorption bands: 520 cm -1 , 780 cm -1 , 1250 cm
-1 , 1320cm -1 , 1380-1440cm -1 doublet (trapezoid), 17
35 cm -1 and 2850 cm -1 and vitamin B12 as a main component, vitamin B2, saponin, diabetes及therapeutic agent consisting of a water-soluble extract containing tannins.
JP4320565A 1992-11-30 1992-11-30 Antidiabetic agent consisting of water-soluble extract from Toberaceae plant Expired - Fee Related JPH0699318B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP4320565A JPH0699318B2 (en) 1992-11-30 1992-11-30 Antidiabetic agent consisting of water-soluble extract from Toberaceae plant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP4320565A JPH0699318B2 (en) 1992-11-30 1992-11-30 Antidiabetic agent consisting of water-soluble extract from Toberaceae plant

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP63247390A Division JPH0296532A (en) 1988-10-03 1988-10-03 Water soluble extract from pittosporaceae plant effective against diabetes mellitus and liver disease and production thereof

Publications (2)

Publication Number Publication Date
JPH05271086A JPH05271086A (en) 1993-10-19
JPH0699318B2 true JPH0699318B2 (en) 1994-12-07

Family

ID=18122856

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4320565A Expired - Fee Related JPH0699318B2 (en) 1992-11-30 1992-11-30 Antidiabetic agent consisting of water-soluble extract from Toberaceae plant

Country Status (1)

Country Link
JP (1) JPH0699318B2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5832714B2 (en) * 2008-06-11 2015-12-16 丸善製薬株式会社 Tyrosinase activity inhibitor and melanin production inhibitor

Also Published As

Publication number Publication date
JPH05271086A (en) 1993-10-19

Similar Documents

Publication Publication Date Title
JP2009132662A (en) Glutathione production promoter
US6455070B1 (en) Composition for treating symptoms of influenza
Dawodu et al. The proximate evaluation and phytochemistry of Enantia chlorantha stem bark in aqueous and ethanolic extract
CA2075077C (en) Stevia extract-containing liquid internal medicine and method of preparing the same
WO2002066041A1 (en) Natural composition
KR101829810B1 (en) Fermented composition containing both forage barley and medicinal herbs extract material, and a preparation method thereof
JPH0699318B2 (en) Antidiabetic agent consisting of water-soluble extract from Toberaceae plant
CN107637817A (en) A kind of health-care honey powder and preparation method thereof
RU2332866C2 (en) Dietary supplement "perstevit"
US5118714A (en) Aqueous extract from pittosporaceae effective for treating diabetes and liver dysfunction
RU2665968C1 (en) Method for obtaining an agent of choleretic, anti-inflammatory and antioxidant activity
US7074436B2 (en) Method for the production of phyllanthus extracts
JP3167777B2 (en) Antiviral, antibacterial and bactericide
Oludare Qualitative and Quantitative Screening of Phytochemical Analysis of Spondiasmombin (Linn.) Extracts (Root, Leaf, and Stem Bark), A Useful Formulation in Drug Discovery
KR0179088B1 (en) Composition containing rhodiola sachalinesis extract for prophylaxis and treatment of diabetes mellitus
RU2099986C1 (en) Concentrate of instant drink "solevit"
Pradhan et al. Phytochemical standardization and antimicrobial activity of methanolic extract of Zingiber officinale
RU2806578C1 (en) Method for producing tea functional food composition for preventive purpose
JP3167776B2 (en) Anticancer / anticancer agent
RU2223107C2 (en) Phytoagent eliciting antituberculosis effect
RU2423996C1 (en) Method of phytopreparation therapy of gastrointestinal diseases in calves
KR100393658B1 (en) Herb composition having anti-inflammatory effect
CN105832840B (en) Application of paliurus ramosissimus or extract thereof in preparation of medicine for treating burns and scalds
RU2382652C1 (en) Therapeutic preparation for young growth of agricultural animals and method for prevention and treatment of gastrointestinal diseases of calves with its application
Abbasi et al. Phytochemical analysis and cytotoxicity evaluation of flowering buds of L.

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 19950523

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees